Disease Modification in Sjogrens Syndrome Measured by Ultrasound: A Pilot Study

NCT03411850 Phase 2 UNKNOWN

Ultrasound study focused on salivary gland outcomes in Sjogren's subjects

Details

Lead sponsor	Arthritis & Rheumatism Associates, P.C.
Phase	Phase 2
Status	UNKNOWN
Enrolment	20
Start date	2016-05
Completion	2021-12

Conditions

• Sjogren's Syndrome

Interventions

• Orencia
• Placebo

Primary outcomes

• Salivary gland changes — 32 weeks
  Salivary gland changes detected by ultrasound imaging with elastography

Countries

United States